Yahoo Web Search

Search results

  1. Bill Gates and Melinda French Gates total giving to the foundation from inception through 2023: $59.5 billion Warren Buffett total giving to the foundation from 2006 through 2023: $39.3 billion Foundation Trust Endowment as of December 31, 2023: $75.2 billion (1) As of December 31, 2023.

  2. Our methods are based on logic, driven by rigor, results, issues, and outcomes. When Bill and Melinda started the foundation twenty years ago, the world didn’t have a decent estimate of how many people were dying of malaria each year. The data just didn’t exist, nor did a scientific way to collect it.

  3. At a glance. Since making our first grants in South Africa in 1999, we have been committed to addressing issues such as the country’s high rates of HIV and tuberculosis (TB), social inequality, and inadequate water and sanitation infrastructure. South Africa has less than 1 percent of the world’s population, but it accounts for 18 percent ...

  4. Grant opportunities. The foundation awards the majority of its grants to U.S. 501 (c) (3) organizations and other tax-exempt organizations identified by our staff. (Tax status definitions) (Glossary of terms) Request for proposals (RFP): We are a nonprofit fighting poverty, disease, and inequity around the world. The foundation awards the ...

  5. We use a standard four-phase process to develop all of our grants and contracts. The duration of each phase depends on the complexity of the project as well as the capacity and geographic location of the prospective partner. Phase 1: Concept Development. Our program officers are experts in their field. They work to identify ideas that support ...

  6. In higher-income countries, rotavirus is easily treated, and a vaccine is available. Stirred by this gross inequity in access to health care, Bill and Melinda resolved to devote themselves to addressing such issues, leading them to establish their foundation. The foundation began working in India in 2003 with the launch of Avahan, an HIV ...

  7. In 2013, the foundation, the Government of Japan, and several Japanese pharmaceutical companies launched the Global Health Innovative Technology (GHIT) Fund, a public-private partnership that creates new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases (NTDs). This innovative model has been replicated ...